Sotera Health (NASDAQ:SHC) Shares Bought by Northern Trust Corp

Northern Trust Corp raised its stake in shares of Sotera Health (NASDAQ:SHC - Free Report) by 23.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,334,367 shares of the company's stock after acquiring an additional 254,768 shares during the period. Northern Trust Corp owned approximately 0.47% of Sotera Health worth $18,254,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in SHC. Two Seas Capital LP increased its holdings in Sotera Health by 624.0% in the 4th quarter. Two Seas Capital LP now owns 2,896,136 shares of the company's stock worth $39,619,000 after acquiring an additional 2,496,136 shares in the last quarter. Norges Bank purchased a new position in shares of Sotera Health in the fourth quarter valued at $12,764,000. Walleye Capital LLC lifted its holdings in shares of Sotera Health by 818.2% in the 4th quarter. Walleye Capital LLC now owns 775,000 shares of the company's stock worth $10,602,000 after acquiring an additional 690,597 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Sotera Health by 27.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company's stock worth $43,004,000 after acquiring an additional 673,979 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Sotera Health by 45.1% in the 4th quarter. Bank of New York Mellon Corp now owns 1,630,736 shares of the company's stock worth $22,308,000 after acquiring an additional 507,147 shares during the last quarter. Institutional investors own 91.03% of the company's stock.

Sotera Health Stock Performance

NASDAQ:SHC traded up $0.06 during trading hours on Friday, hitting $12.80. 948,002 shares of the company were exchanged, compared to its average volume of 1,201,775. The stock has a market capitalization of $3.63 billion, a price-to-earnings ratio of 51.20 and a beta of 1.88. Sotera Health has a 52-week low of $9.53 and a 52-week high of $17.08. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The company's 50 day moving average price is $11.57 and its 200-day moving average price is $12.86.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.12 by $0.02. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business had revenue of $254.52 million during the quarter, compared to analysts' expectations of $245.56 million. During the same period in the previous year, the business posted $0.13 EPS. The business's quarterly revenue was up 2.6% compared to the same quarter last year. As a group, research analysts forecast that Sotera Health will post 0.61 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts recently commented on SHC shares. Piper Sandler reduced their price target on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 23rd. Barclays cut their price objective on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. Finally, The Goldman Sachs Group raised shares of Sotera Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $14.00 to $17.00 in a research report on Monday, May 5th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $15.80.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.